乳腺癌患者TIVAP相关性血栓形成危险因素及护理干预研究进展
Research Progress of TIVAP Associated Thrombosis Risk Factors and Nursing Intervention in Breast Cancer Patients
摘要: 完全植入式静脉输液港因其具有留置时间长、维护间隔周期长、无导管外露、更加方便经济等特点而广泛应用于临床中的乳腺癌患者。虽然TIVAP给患者及医护人员都带来了较大的便利，但是出现相应并发症的概率也很高，一旦发生血栓栓塞事件，将严重危及患者生命安全。本文通过分析国内外相关文献，就乳腺癌患者应用输液港发生血栓这一不良事件的类型、表现、影响因素和预防等方面进行综述，以期提高临床护理人员对此并发症的关注，同时为预防乳腺癌患者TIVAP相关性血栓提供临床参考。
Abstract: Totally implantable venous ports are widely used in clinical breast cancer pa-tients due to their characteristics of long indentation time, long maintenance interval period, no catheter exposure and more convenient and economical. Although TIVAP brings great convenience to both patients and medical staff, the incidence of complications is also very high. Once thrombo-embolism occurs, it will seriously endanger the life safety of patients. Based on the analysis of rele-vant literature at home and abroad, this paper summarized the types, manifestations, influencing factors and prevention of the adverse events of thrombus in breast cancer patients using the infu-sion port, in order to improve the attention of clinical nursing staff to this complication and provide a clinical reference for the prevention of TIVAP-related thrombus in breast cancer patients.
文章引用：涂琎, 李金秀, 彭涛, 张帆, 田宏艳, 周晓辉. 乳腺癌患者TIVAP相关性血栓形成危险因素及护理干预研究进展[J]. 护理学, 2023, 12(2): 115-121. https://doi.org/10.12677/NS.2023.122017

参考文献

[1] 徐海萍, 周琴, 韩伟, 鲁婷婷, 陶娟. 手臂输液港与胸壁输液港常见并发症发生率比较的Meta分析[J]. 中华护理杂志, 2018, 53(3): 352-358.
[2] Siu, A.L. (2016) Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 164, 279-296. [Google Scholar] [CrossRef] 
[3] Torre, L.A., et al. (2015) Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87-108. [Google Scholar] [CrossRef] [PubMed]
[4] 黄海云. 植入式输液港在乳腺癌化疗应用中与PICC的优势对比[J]. 实用临床护理学电子杂志, 2020, 5(13): 60+63.
[5] Gurkan, S., et al. (2015) Retrospective Evaluation of Totally Im-plantable Venous Access Port Devices: Early and Late Complications. Journal of BUON: Official Journal of the Balkan Union of Oncology, 20, 338-345.
[6] 熊白玉, 朱玮. 乳腺癌化疗患者完全输液港相关血栓形成的因素分析[J]. 广州医药, 2021, 52(6): 54-58.
[7] Hartkamp, A., Boxtel, A.J., Zonnenberg, B.A., et al. (2000) Totally Implantable Venous Access Devices: Evaluation of Complications and a Prospective Comparative Study of Two Different Port Sys-tems. The Netherlands Journal of Medicine, 57, 215-223. [Google Scholar] [CrossRef] 
[8] Baskin, J.L., et al. (2009) Management of Occlusion and Thrombosis Associated with Long-Term Indwelling Central Venous Catheters. The Lancet, 374, 159-169. [Google Scholar] [CrossRef] 
[9] 张悦, 周演铃, 周晓韩. 肿瘤病人输液港相关血栓事件的研究进展[J]. 循证护理, 2022, 8(10): 1343-1346.
[10] Kearon, C., et al. (2016) Antithrombotic Therapy for VTE Disease. Chest, 149, 315-352. [Google Scholar] [CrossRef] [PubMed]
[11] Wildgruber, M., et al. (2016) Polyurethane Versus Silicone Cath-eters for Central Venous Port Devices Implanted at the Forearm. European Journal of Cancer, 59, 113-124. [Google Scholar] [CrossRef] [PubMed]
[12] Busch, J.D., et al. (2017) Complication Rates Observed in Silicone and Polyurethane Catheters of Totally Implanted Central Venous Access Devices Implanted in the Upper Arm. Journal of Vascular and Interventional Radiology, 28, 1177-1183. [Google Scholar] [CrossRef] [PubMed]
[13] Spencer, T.R. and Mahoney, K.J. (2017) Reducing Catheter-Related Thrombosis Using a Risk Reduction Tool Centered on Cath-eter to Vessel Ratio. Journal of Thrombosis and Thrombolysis, 44, 427-434. [Google Scholar] [CrossRef] [PubMed]
[14] Sharp, R., et al. (2015) The Catheter to Vein Ratio and Rates of Symptomatic Venous Thromboembolism in Patients with a Peripherally Inserted Central Catheter (PICC): A Prospective Cohort Study. International Journal of Nursing Studies, 52, 677-685. [Google Scholar] [CrossRef] [PubMed]
[15] 完全植入式输液港上海专家共识[J]. 介入放射学杂志, 2015, 24(12): 1029-1033.
[16] Liu, Y., et al. (2020) Comparison between Arm Port and Chest Port for Optimal Vascular Access Port in Patients with Breast Cancer: A Systematic Review and Meta-Analysis. BioMed Research International, 2020, Article ID: 9082924. [Google Scholar] [CrossRef] [PubMed]
[17] 吴孝红, 陈惜遂, 张红, 张恬恬. 三种路径植入静脉输液港安全性的Meta分析[J]. 中华护理杂志, 2019, 54(10): 1551-1558.
[18] 王啟瑶, 莫霖, 李霞, 张萍, 黄先巧. 颈内静脉与锁骨下静脉植入静脉输液港的有效性和安全性的Meta分析[J]. 解放军护理杂志, 2018, 35(22): 34-39+47.
[19] Aw, A., et al. (2012) Incidence and Predictive Factors of Symptomatic Thrombosis Related to Periph-erally Inserted Central Catheters in Chemotherapy Patients. Thrombosis Research, 130, 323-326. [Google Scholar] [CrossRef] [PubMed]
[20] 杨敏, 谢俊英, 谭培昭, 吴晓明, 于雷. 动态监测D-二聚体在肿瘤患者导管相关性血栓的临床意义[J]. 实用肿瘤学杂志, 2019, 33(5): 425-430.
[21] Chen, P., Wan, G. and Zhu, B. (2021) Incidence and Risk Factors of Symptomatic Thrombosis Related to Peripherally Inserted Central Catheter in Patients with Lung Cancer. Journal of Advanced Nursing, 77, 1284-1292. [Google Scholar] [CrossRef] [PubMed]
[22] Wang, T.F., Billett, H.H., Connors, J.M., et al. (2021) Approach to Can-cer-Associated Thrombosis: Challenging Situations and Knowledge Gaps. The Oncologist, 26, e17-e23. [Google Scholar] [CrossRef] [PubMed]
[23] Fuentes, H.E., Tafur, A.J. and Caprini, J.A. (2016) Cancer-Associated Thrombosis. Disease-a-Month, 62, 121-158. [Google Scholar] [CrossRef] [PubMed]
[24] Ellis, M.L., et al. (2020) Catheter-Related Thrombosis Inci-dence and Risk Factors in Adult Cancer Patients with Central Venous Access Devices. Internal Medicine Journal, 50, 1475-1482. [Google Scholar] [CrossRef] [PubMed]
[25] Makary, M.S., et al. (2019) Advanced Stage Breast Cancer Is Associated with Catheter-Tip Thrombus Formation Following Implantable Central Venous Port Placement. Phlebology, 34, 107-114. [Google Scholar] [CrossRef] [PubMed]
[26] Liu, Y.X., et al. (2015) Peripherally Inserted Central Catheter Thrombosis Incidence and Risk Factors in Cancer Patients: A Double-Center Prospective Investigation. Therapeutics and Clinical Risk Management, 11, 153-160. [Google Scholar] [CrossRef] 
[27] Jennifer, M., et al. (2014) Screening for Novel Risk Factors Related to Peripherally Inserted Central Catheter-Associated Complications. Journal of Hospital Medicine, 9, 481-489. [Google Scholar] [CrossRef] [PubMed]
[28] 刘斌亮, 谢俊英, 王延风, 易宗毕, 管秀雯, 黎立喜, 翟婧彤, 李慧, 李红, 马飞. 乳腺癌患者中心静脉置管导管相关性血栓的发生情况及其影响因素[J]. 中华肿瘤杂志, 2021, 43(8): 838-842.
[29] 刘运江, 屈翔, 葛智成, 马力. 乳腺癌植入式静脉输液港临床应用专家共识及技术操作指南(2017) [J]. 中国实用外科杂志, 2017, 37(12): 1377-1382. [Google Scholar] [CrossRef] 
[30] Schiffer, C.A., Mangu, P.B., Wade, J.C., et al. (2013) Central Venous Catheter Care for the Patient with Cancer: American Society of Clinical Oncology Clinical Prac-tice Guideline. Journal of Clinical Oncology, 31, 1357-1370. [Google Scholar] [CrossRef] 
[31] 《中国血栓性疾病防治指南》专家委员会. 中国血栓性疾病防治指南[J]. 中华医学杂志, 2018, 98(36): 2861-2888.
[32] Mulder, F.I., Candeloro, M., Kamphuisen, P.W., et al. (2019) The Khorana Score for Prediction of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis. Haematologica, 104, 1277-1287. [Google Scholar] [CrossRef] [PubMed]
[33] Saber, W., et al. (2011) Risk Factors for Catheter-Related Thrombosis (CRT) in Cancer Patients: A Patient-Level Data (IPD) Meta-Analysis of Clinical Trials and Prospective Studies. Journal of Thrombosis and Haemostasis, 9, 312-319. [Google Scholar] [CrossRef] [PubMed]
[34] Gorski, L.A. (2017) The 2016 Infusion Therapy Standards of Practice. Home Healthcare Now, 35, 10-18. [Google Scholar] [CrossRef] 
[35] Carla, F., et al. (2019) Eight-Week Interval in Flushing and Locking Port-a-Cath in Cancer Patients: A Single-Institution Experience and Systematic Review. European Journal of Cancer Care, 28, e12978. [Google Scholar] [CrossRef] [PubMed]
[36] Köksoy, C., et al. (1995) The Diagnostic Value of Colour Doppler Ultra-sound in Central Venous Catheter Related Thrombosis. Clinical Radiology, 50, 687-689. [Google Scholar] [CrossRef] 
[37] 崔露萍, 吴荷玉, 褚婕. 术中使用间歇充气加压装置对术后静脉血栓影响的Meta分析[J]. 护理研究, 2020, 34(17): 3034-3040.
[38] Bulent, G. (2021) Risk Factors Associ-ated with Warfarin Overdose and Complications Related to Warfarin Overdose in the Emergency Department. Drug and Chemical Toxicology, 45, 1732-1738. [Google Scholar] [CrossRef] [PubMed]
[39] 完全植入式输液港上海专家共识(2019) [J]. 介入放射学杂志, 2019, 28(12): 1123-1128.
[40] 公茂峰, 陈国平, 顾建平. 下肢深静脉血栓形成的溶栓治疗现状与尿激酶、阿替普酶的临床应用[J]. 中华介入放射学电子杂志, 2017, 5(4): 282-287.

为你推荐